Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 912

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 912
---
 The market risk premium of 10.97%, as published by Bloomberg at the end of December 2022.

| Category       |     | Amount |     | Note                                                                                                                 |
| Kd             |     | 12.29% |     | Corporate Bond (Unsecured 5 Year)BBB- 5 Year Corporate Bond Yields                                                   |
| Rf             |     |  3.73% |     | South Korea’s 10-year government bond yield courtesy of Bloomberg                                                    |
| Rm – Rf        
 (Risk Premium) |     | 10.97% |     | Korea Market Risk Premium powered by Bloomberg (averaged over the past year prior to the valuation date)             |
| ß              |     | 0.7291 |     | he beta value and target capital structure of the client company due to its industry. (debt : equity=10.99%: 89.01%) |
| Ke             |     | 11.73% |     | Cost of equity                                                                                                       |

Annex I-34 ANNEX J FORM OF PROXY CARD YOUR VOTE IS IMPORTANT. PLEASE VOTE TODAY. Vote by Internet - QUICK EASY IMMEDIATE - 24 Hours a Day, 7 Days a Week or by Mail 2025 BELLEVUE LIFE SCIENCES ACQUISITION CORP. Your Internet vote authorizes the named proxies to vote your shares in the same manner as if you marked, signed and returned your proxy card. Votes submitted electronically over the Internet must be received by 11:59 p.m., Eastern Time, on February 12, 2025. INTERNET – www.cstproxyvote.com Use the Internet to vote your proxy. Have your proxy card available when you access the above website. Follow the prompts to vote your shares. MAIL – Mark, sign and date your proxy card and return it in the postage-paid envelope provided. PLEASE DO NOT RETURN THE PROXY CARD IF YOU ARE VOTING ELECTRONICALLY. FOLD HERE • DO NOT SEPARATE • INSERT IN ENVELOPE PROVIDED THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS BELLEVUE LIFE SCIENCES ACQUISITION CORP. The undersigned, revoking any previous proxies relating to these shares, hereby acknowledges receipt of the notice and proxy statement, dated [ ––––– ], 2025, (the “Proxy Statement”) in connection with the Special Meeting of stockholders of Bellevue Life Sciences